Press
Keep up-to-date with relevant news, important announcements and key market insights.
About Bionical Emas
Bionical Emas is the only Contract Research Organization that combines Clinical Development, Clinical Trial Supply (CTS) and Early Access Programs (EAP) to deliver a unique, seamless approach to bring life-changing medicines to patients around the world.
READ MORE
Bionical Emas launches Expanded Access Program for JZP458 – a recombinant Erwinia Asparaginase
Press Release
READ MORE
Bionical Emas launches Managed Access Program for JZP 458 – a recombinant Crisantaspase produced in Pseudomonas fluorescens
Press Release
READ MORE
Webinar: Bionical Emas Panel: Challenges and Solutions Through Real World Data Capture in EAP
Resource
READ MORE
Webinar: Key Patient Focused Considerations to Successfully Operationalize an EAP
Resource
READ MORE
Webinar: The importance of Real World Data Collection through Early Access Programs
Resource
2 / 3